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Introduction
Sinonasal Malignant Melanoma with Diffuse Carci-
nomatosis: Initial PET/CT Staging and Follow-up 
CT/MR Imaging 
Ba D. Nguyen, M.D.
Mucosal malignant melanoma of the head and neck is a rare but aggressive type of melanoma with poor 
clinical prognosis and outcome. Its nonspecific symptomatology frequently leads to its delayed diag-
nosis until advanced stages of the disease. The author presents a case of primary sinonasal amelanotic 
melanoma with preoperative F-18 FDG PET/CT showing diffuse bone metastasis only two months 
after the onset of epistaxis and nasal congestion, and subsequent postsurgical CT/MR showing diffuse 
soft tissue tumor dissemination and malignant pleural effusion.
Sinonasal melanoma is an uncommon malignancy dif-
ficult to diagnose due to its hidden locations of the head 
and neck and due to its deceptive symptoms. Contrary to 
its cutaneous counterpart, sinonasal melanoma has a high 
propensity for metastasis and a poor survival rate despite 
aggressive therapy. To illustrate the unpredictable behavior 
of such neoplasm, the author presents a case of advanced 
disease at initial diagnosis with accelerated hepatic, pleural, 
peritoneal and retroperitoneal dissemination.
Case Report
A 56-year-old woman came to our institution with a 
2-month history of nasal congestion and epistaxis. Otorhi-
nologic consultation found a left nasal mass, the biopsy of 
which yielded histologic evidence of primary sinonasal ma-
lignant melanoma (SMM). Head and neck MR examina-
tion showed a hypervascular lesion of the left nasal cavity 
extending to the anterior left ethmoid air cells and frontal 
sinuses. There was no orbital or intracranial tumor involve-
ment. A preoperative F-18 FDG PET/CT staging study 
confirmed the hypermetabolic left SMM (Figure 1). It also 
showed diffuse foci of abnormal radiotracer uptake in the 
axial and appendicular skeleton compatible with diffuse 
osseous metastasis (Figure 2). Shortly after the PET/CT 
imaging, the patient underwent tumor resection with left 
lateral rhinotomy and maxillectomy. The surgical specimen 
was consistent with a left amelanotic SMM with exten-
sive ulceration and no host response. The tumor showed 
about 20 mitotic figures per mm2 with strong positivity 
for HMB 45 and Melan-A. There was lymphovascular and 
perineural tumor involvement.
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Figure 1. 56-year-old woman with sinonasal amelanotic 
melanoma. Composite PET/CT image (sequence: CT, PET, 
Fused PET/CT in the coronal, sagittal and axial projections) 
shows a high metabolic lesion within the left nasal cavity 
extending to the left ethmoid sinuses (crosshair).
Figure 2. Anterior MIP PET image shows, in addition to the 
left sinonasal melanoma, diffuse foci of abnormal F-18 FDG 
uptake at the entire spine, shoulder and pelvic girdles, and 
long bones of extremities related to diffuse osseous metas-
tases.
Spine MR examination, performed three weeks after 
PET/CT, showed diffuse bone marrow signal intensity 
changes from osseous tumor infiltration and detected 
new prevertebral adenopathy not seen on initial PET/
CT (Figure 3). Ensuing iliac crest biopsy showed near 
total effacement of normal marrow, which was replaced by 
tumor cells identical to the ones from the sinonasal mass. 
CT, following the MR examination, showed diffuse tumor 
dissemination to lungs, liver, mesentery, peritoneum and 
retroperitoneum, and bilateral malignant pleural effusion 
(figure 4). These features of advanced carcinomatosis were 
not conspicuous on the preoperative PET or co-registered 
multi-detector CT staging examination. The patient 
developed progressive clinical deterioration with hypoxia, 
anasarca and pancytopenia from diffuse bone marrow 
tumor infiltration. She passed away less than two months 
after SMM surgery.
Discussion
SMM is an uncommon tumor accounting for 0.3-2% 
of all malignant melanomas, 4% of head and neck mela-
nomas and 4% of all sinonasal neoplasms [1]. At least one 
third of SMM are amelanotic [2, 3]. SMM has equal gen-
der distribution targeting a patient population of 6 decades 
of life [1, 4]. It arises predominantly from nasal cavity or 
nasal cavity and sinuses [5]. The nonspecific symptoms, 
which include epistaxis, nasal congestion and obstruc-
tion, nasal discharge and pain, may prolong the duration 
between SMM onset and its definitive diagnosis. Diplopia, 
proptosis and neurological symptomatology are usually 
findings of advanced stages of the disease with orbital and 
intracranial invasion. SMM has a high propensity to dis-
seminate due to the rich lymphatic and vascular network 
of the sinonasal tract. The metastatic status is the most 
important factor for prognosis and outcome of the disease 
[1]. Additional prognostic factors include patient’s age, 
mitotic characteristics of the melanoma, tumor thickness, 
involvement of the nasopharynx, nasal obstruction, vascu-
lar invasion and tumor recurrence [1, 6, 7]. SMM is a very 
aggressive malignancy with 5-year and 10-year survival 
rates ranging from 10 to 47% and 20 to 24.3% respective-
ly [6]. CT and MR are the main imaging modalities for 
detailed anatomic evaluation of local tumor involvement 
[2]. MR provides different patterns of tumor intensity 
changes on T1 and T2-weighted sequences depending on 
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Figure 3. Sagittal T1-weighted MR image of the thoracic 
spine, obtained 3 weeks after sinonasal surgery, shows dif-
fuse abnormally decreased signal intensity of the bone mar-
row comparing to the signal intensity of adjacent vertebral 
disks. There is prevertebral and retrocrural adenopathy (ar-
rows), which was not present on initial PET/CT examination.
the melanotic or amelanotic constitution of SMM [8]. 
Comparing to conventional cross-sectional imaging, F-18 
FDG PET/CT provides a more comprehensive whole-
body assessment thus is more able to detect regional nodal 
and distant metastasis, which could be present at the initial 
presentation of the disease [9-12]. PET is based on high 
glucose metabolism of melanoma and may not distinguish 
a melanotic variant from an amelanotic one. Treatment 
consists of aggressive surgery for local control of SMM. 
Complete resection of the malignancy may difficult due 
to involvement of adjacent vital structures of the head and 
neck. Post-operative radiation therapy may have limited 
positive impact on the survival rate [13, 14]. Chemo-
immunotherapy still needs clinical validation [6].
In this patient, the accelerated tumor dissemination 
in the immediate postoperative course may be related to 
combining factors of aggressive sinonasal melanoma be-
havior, markedly depressed immune system of the patient 
and traumatic maxillofacial surgery releasing malignant 
cells into the systemic circulation. Alternatively, the diffuse 
soft tissue metastasis may exist at microscopic level by 
Figure 4. Axial CT image of the abdomen, obtained 3 weeks 
after sinonasal surgery, shows diffuse metastases involving 
the liver, peritoneum and retroperitoneum (arrows).
the time of the PET/CT staging beyond the resolution of 
this modality. PET has known limitation for evaluating 
small tumors and for assessing subtle liver lesions due to 
physiologic background tracer uptake of this organ [15, 
16]. The initial PET staging with its co-registered multi-
detector CT did not show any obvious liver metastasis or 
peritoneal/mesenteric carcinomatosis. These lesions may 
rapidly progress in this immunodepressed patient after 
major head and neck surgery [17]. 
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